Neurisol (Gabapentin)

Gabapentin, the active ingredient in Neurisol, is a gabapentinoid presented as a tablet for oral use. It treats epilepsy, neuropathic pain, postherpetic neuralgia and restless legs syndrome in adults.

GNH USA supplies Neurisol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Gabapentin is used to manage several neurological conditions that involve abnormal neuronal excitability.

Epilepsy: reduces the frequency of seizures in patients with partial onset seizures. Neuropathic pain: alleviates pain associated with diabetic peripheral neuropathy and other nerve injuries. Postherpetic neuralgia: diminishes persistent pain following shingles. Restless legs syndrome: improves uncomfortable sensations and urges to move the legs.

Gabapentin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities. - Visual disturbances: blurred vision or double vision. - Weight gain: gradual increase in body weight. - Gastrointestinal upset: nausea, constipation or abdominal discomfort.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Respiratory depression: slowed or shallow breathing, especially when combined with other depressants. - Acute renal failure: sudden loss of kidney function in susceptible individuals. - Blood dyscrasias: rare cases of leukopenia or thrombocytopenia. - Hepatotoxicity: abnormal liver function tests or hepatitis.

Before prescribing Gabapentin, clinicians should consider patient‑specific factors and monitor for adverse events.

Renal impairment: adjust dose in patients with reduced kidney function. Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression. Suicidal ideation: assess mental health status regularly during treatment. Driving and machinery: advise patients about possible dizziness or drowsiness. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Gabapentin can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption; separate administration by at least 2 hours. - Opioids: combined use may increase risk of respiratory depression and profound sedation. - CNS depressants (e.g., benzodiazepines, barbiturates): may potentiate central nervous system depression.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal impairment, especially in patients with pre‑existing kidney disease. - Antihypertensives: gabapentin may enhance hypotensive effects. - Alcohol: concurrent use can exacerbate dizziness and drowsiness. - Diuretics: monitor electrolytes and renal function when used together.